Rotavirus Burden and Genotypes in a Sentinel Hospital Surveillance System in Lebanon
NCT01321216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1555
Last updated 2023-11-18
Summary
This study aims to determine the contribution of rotavirus infection as a cause of gastroenteritis requiring hospitalization in children younger than 5 years of age. Additionally, a secondary aim will be to determine the genotypes of rotavirus that cause these infections as prevalent in Lebanon.
Conditions
Sponsors & Collaborators
-
Makassed General Hospital
collaborator OTHER -
Rafic Hariri University Hospital
collaborator OTHER -
Hotel Dieu de France Hospital
collaborator OTHER -
Hammoud Hospital University Medical Center
collaborator OTHER_GOV -
Hopital Nini
collaborator OTHER -
Nabatieh Governmental Hospital
collaborator OTHER -
American University of Beirut Medical Center
lead OTHER
Eligibility
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- Lebanon
Study Locations
More Related Trials
-
A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and Latvia
NCT01733849 ·Status: COMPLETED
-
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™
NCT01435967 ·Status: COMPLETED
-
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
NCT01026779 ·Status: COMPLETED
-
Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)
NCT01633190 ·Status: UNKNOWN
-
Effectiveness of Monovalent Rotavirus Vaccine (RV1)
NCT01871038 ·Status: COMPLETED
-
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
NCT05958771 ·Status: UNKNOWN ·Phase: PHASE3
-
Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation)
NCT02902445 ·Status: COMPLETED
-
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007
NCT01563146 ·Status: COMPLETED
-
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa
NCT04658914 ·Status: COMPLETED ·Phase: PHASE2
-
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
NCT01563159 ·Status: COMPLETED
-
Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study
NCT03271593 ·Status: COMPLETED
-
Vaccine Effectiveness of RV1 in a Naïve Population
NCT01467037 ·Status: COMPLETED
-
Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
NCT01339221 ·Status: COMPLETED
-
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
NCT00740935 ·Status: COMPLETED ·Phase: PHASE4
-
Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model
NCT04123119 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
NCT01575197 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis
NCT01733862 ·Status: COMPLETED
-
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
NCT01236066 ·Status: COMPLETED
-
Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults
NCT02669121 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 ·Status: COMPLETED
-
Rotavirus Vaccine Produced by Butantan Institute
NCT00981669 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase III Clinical Trial to Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Vaccine (ORV) 116E
NCT01305109 ·Status: UNKNOWN ·Phase: PHASE3
-
Epidemiology of Rotavirus Infection in North India Community
NCT01508533 ·Status: COMPLETED
-
ROTATEQ Reexamination Study (V260-037)
NCT01074242 ·Status: COMPLETED
-
A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)
NCT01600092 ·Status: COMPLETED ·Phase: PHASE3